Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,310
archived clinical trials in
Allergy

Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
Randomized, Double-Blind Trial of the Safety and Efficacy of Dymista Nasal Spray Compared to Placebo Nasal Spray in the Treatment of Children Ages >4 Years to <12 Years With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  11/12/2013
Sylvana Research Associates
mi
from
San Antonio, TX
Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
Randomized, Double-Blind Trial of the Safety and Efficacy of Dymista Nasal Spray Compared to Placebo Nasal Spray in the Treatment of Children Ages >4 Years to <12 Years With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 11/12/2013
Sylvana Research Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
Randomized, Double-Blind Trial of the Safety and Efficacy of Dymista Nasal Spray Compared to Placebo Nasal Spray in the Treatment of Children Ages >4 Years to <12 Years With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  11/12/2013
Allergy and Asthma Research Institute
mi
from
Waco, TX
Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
Randomized, Double-Blind Trial of the Safety and Efficacy of Dymista Nasal Spray Compared to Placebo Nasal Spray in the Treatment of Children Ages >4 Years to <12 Years With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 11/12/2013
Allergy and Asthma Research Institute
mi
from
Waco, TX
Click here to add this to my saved trials
Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
Randomized, Double-Blind Trial of the Safety and Efficacy of Dymista Nasal Spray Compared to Placebo Nasal Spray in the Treatment of Children Ages >4 Years to <12 Years With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  11/12/2013
Immunology/allergy and asthma Care of Waco
mi
from
Waco, TX
Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR)
Randomized, Double-Blind Trial of the Safety and Efficacy of Dymista Nasal Spray Compared to Placebo Nasal Spray in the Treatment of Children Ages >4 Years to <12 Years With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 11/12/2013
Immunology/allergy and asthma Care of Waco
mi
from
Waco, TX
Click here to add this to my saved trials
Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests
Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests
Status: Enrolling
Updated:  11/15/2013
Martha Morehouse Medical Plaza, 2050 Kenny Rd,Suite 2200 and Suite 2600
mi
from
Columbus, OH
Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests
Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin Tests
Status: Enrolling
Updated: 11/15/2013
Martha Morehouse Medical Plaza, 2050 Kenny Rd,Suite 2200 and Suite 2600
mi
from
Columbus, OH
Click here to add this to my saved trials
Single Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Subjects
Status: Enrolling
Updated:  11/21/2013
Clinical Research Facility
mi
from
Overland Park, KA
Single Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Subjects
Status: Enrolling
Updated: 11/21/2013
Clinical Research Facility
mi
from
Overland Park, KA
Click here to add this to my saved trials
Single Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Subjects
Status: Enrolling
Updated:  11/21/2013
Clinical Research Facility
mi
from
Baltimore, MD
Single Ascending-dose Study of the Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Subjects
Status: Enrolling
Updated: 11/21/2013
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 2/3 Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis
A Single Center, Randomized, Double-Masked, Vehicle Controlled Phase 2/3 Study Evaluating the Efficacy and Safety of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model (CAC™)
Status: Enrolling
Updated:  2/12/2014
ORA Inc
mi
from
Andover, MA
Phase 2/3 Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis
A Single Center, Randomized, Double-Masked, Vehicle Controlled Phase 2/3 Study Evaluating the Efficacy and Safety of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis Using a Modified Conjunctival Allergen Challenge Model (CAC™)
Status: Enrolling
Updated: 2/12/2014
ORA Inc
mi
from
Andover, MA
Click here to add this to my saved trials
Walnut Oral Immunotherapy for Tree Nut Allergy
Walnut Oral Immunotherapy for Tree Nut Allergy-CHOP
Status: Enrolling
Updated:  2/19/2014
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Walnut Oral Immunotherapy for Tree Nut Allergy
Walnut Oral Immunotherapy for Tree Nut Allergy-CHOP
Status: Enrolling
Updated: 2/19/2014
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects
A Bi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of STAHIST in Adult Subjects With a History of Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  3/24/2014
South Bend Clinic
mi
from
South Bend, IN
Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects
A Bi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of STAHIST in Adult Subjects With a History of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/24/2014
South Bend Clinic
mi
from
South Bend, IN
Click here to add this to my saved trials
Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects
A Bi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of STAHIST in Adult Subjects With a History of Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  3/24/2014
Family Allergy and Asthma Research Institute
mi
from
Louisville, KY
Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects
A Bi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study Evaluating the Safety and Efficacy of STAHIST in Adult Subjects With a History of Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 3/24/2014
Family Allergy and Asthma Research Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older
Status: Enrolling
Updated:  3/31/2014
Clinical Research Atlanta
mi
from
Stockbridge, GA
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older
Status: Enrolling
Updated: 3/31/2014
Clinical Research Atlanta
mi
from
Stockbridge, GA
Click here to add this to my saved trials
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older
Status: Enrolling
Updated:  3/31/2014
Family Allergy and Asthma Institute
mi
from
Louisville, KY
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older
Status: Enrolling
Updated: 3/31/2014
Family Allergy and Asthma Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older
Status: Enrolling
Updated:  3/31/2014
National Allergy, Asthma & Urticaria Centers of Charleston, PA
mi
from
Charleston, SC
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older
Status: Enrolling
Updated: 3/31/2014
National Allergy, Asthma & Urticaria Centers of Charleston, PA
mi
from
Charleston, SC
Click here to add this to my saved trials
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older
Status: Enrolling
Updated:  3/31/2014
Central Texas Health Research
mi
from
New Braunfels, TX
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
A Phase 2, Double-Blind, Parallel-Group, Dose-Ranging Study Evaluating Safety/ Efficacy Atropine Doses With Pseudoephedrine and Chlorpheniramine in SAR Patients 12 Years of Age and Older
Status: Enrolling
Updated: 3/31/2014
Central Texas Health Research
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
A Prospective, Randomized, Double-Masked, Vehicle and Active-Controlled, Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for the Treatment of Allergic Conjunctivitis in an Environmental Exposure Chamber (EEC) Model
Status: Enrolling
Updated:  4/17/2014
Alcon Call Center
mi
from
Fort Worth, TX
Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
A Prospective, Randomized, Double-Masked, Vehicle and Active-Controlled, Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for the Treatment of Allergic Conjunctivitis in an Environmental Exposure Chamber (EEC) Model
Status: Enrolling
Updated: 4/17/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Center for Dermatology Clinical Research
mi
from
Fremont, CA
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Center for Dermatology Clinical Research
mi
from
Fremont, CA
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Torrance Clinical Research Institute Inc.
mi
from
Lomita, CA
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Torrance Clinical Research Institute Inc.
mi
from
Lomita, CA
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Stanford University, Medical Dermatology
mi
from
Redwood City, CA
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Stanford University, Medical Dermatology
mi
from
Redwood City, CA
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
UCSD Dermatology
mi
from
San Diego, CA
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
UCSD Dermatology
mi
from
San Diego, CA
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
The Center for Clinical and Cosmetic Research
mi
from
Aventura, FL
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
The Center for Clinical and Cosmetic Research
mi
from
Aventura, FL
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Dermatology of Boca
mi
from
Boca Raton, FL
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Dermatology of Boca
mi
from
Boca Raton, FL
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Skin Care research Inc
mi
from
Boca Raton, FL
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Skin Care research Inc
mi
from
Boca Raton, FL
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Olympian Clinical Research
mi
from
Tampa, FL
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Olympian Clinical Research
mi
from
Tampa, FL
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Advanced Medical Research, Inc.
mi
from
Atlanta, GA
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Advanced Medical Research, Inc.
mi
from
Atlanta, GA
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Shideler Clinical Research Center
mi
from
Carmel, IN
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Shideler Clinical Research Center
mi
from
Carmel, IN
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
The Indiana Clinical Trials Center, PC
mi
from
Plainfield, IN
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Grekin Skin Institue
mi
from
Warren, MI
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Grekin Skin Institue
mi
from
Warren, MI
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Minnesota Clinical Study Center
mi
from
Fridley, MN
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Quality Clinical Research, Inc.
mi
from
Omaha, NE
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Comprehensive Clinical Research
mi
from
Berlin, NJ
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Comprehensive Clinical Research
mi
from
Berlin, NJ
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
The Dermatology Group, P.C.
mi
from
Verona, NJ
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
The Dermatology Group, P.C.
mi
from
Verona, NJ
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Skin Search of Rochester, Inc
mi
from
Rochester, NY
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Skin Search of Rochester, Inc
mi
from
Rochester, NY
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Dermatology Consulting Services
mi
from
High Point, NC
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Baker Allergy, Asthma and Dermatology Research Center
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Temple University
mi
from
Philadelphia, PA
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Temple University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Suzanne Bruce & Associates, PA
mi
from
Houston, TX
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Suzanne Bruce & Associates, PA
mi
from
Houston, TX
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Pfugerville Dermatology
mi
from
Pfugerville, TX
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Pfugerville Dermatology
mi
from
Pfugerville, TX
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Dermatology Clinical Research Center of San Antonio
mi
from
San Antonio, TX
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Dermatology Clinical Research Center of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Westend Dermatology Associates
mi
from
Richmond, VA
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Westend Dermatology Associates
mi
from
Richmond, VA
Click here to add this to my saved trials
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated:  6/25/2014
Marycliff Allergy Specialist
mi
from
Spokane, WA
VPD-737 for Treatment of Chronic Pruritus
A Phase II Randomized, Double Blind, Parallel Group, Placebo-Controlled Dose Finding and Efficacy Study of VPD-737 in the Treatment of Subjects With Chronic Pruritus
Status: Enrolling
Updated: 6/25/2014
Marycliff Allergy Specialist
mi
from
Spokane, WA
Click here to add this to my saved trials
A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device
A Safety and Immunogenicity Phase IC Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device
Status: Enrolling
Updated:  8/7/2014
East-West Medical Research Institute
mi
from
Honolulu, HI
A Safety and Immunogenicity Phase IC Study of CryJ2 -DNA-LAMP Plasmid Vaccine for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device
A Safety and Immunogenicity Phase IC Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid for Assessment of Intradermal (ID) Route of Administration Using the Biojector 2000 Device
Status: Enrolling
Updated: 8/7/2014
East-West Medical Research Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated:  8/14/2014
Clinical Research Facility
mi
from
Birmingham, AL
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated: 8/14/2014
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated:  8/14/2014
Clinical Research Facility
mi
from
Goodyear, AZ
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated: 8/14/2014
Clinical Research Facility
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated:  8/14/2014
Clinical Research Facility
mi
from
Jonesboro, AR
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated: 8/14/2014
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated:  8/14/2014
Clinical Research Facility
mi
from
Little Rock, AR
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated: 8/14/2014
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated:  8/14/2014
Clinical Research Facility
mi
from
Encinitas, CA
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated: 8/14/2014
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated:  8/14/2014
Clinical Research Facility
mi
from
Fresno, CA
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated: 8/14/2014
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated:  8/14/2014
Clinical Research Facility
mi
from
Huntington Beach, CA
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated: 8/14/2014
Clinical Research Facility
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated:  8/14/2014
Clinical Research Facility
mi
from
Irvine, CA
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated: 8/14/2014
Clinical Research Facility
mi
from
Irvine, CA
Click here to add this to my saved trials
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated:  8/14/2014
Clinical Research Facility
mi
from
La Jolla, CA
Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
A One-year Placebo-Controlled Study Evaluating the Efficacy and Safety of the House Dust Mite Sublingual Allergen Immunotherapy Tablet (SCH 900237/MK 8237) in Children and Adult Subjects With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma (Protocol No. P05607/001)
Status: Enrolling
Updated: 8/14/2014
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials